Get all your news in one place.
100's of premium titles.
One app.
Start reading
MarketBeat
MarketBeat
Business
Sam Quirke

FORGOTTEN HISTORY: Modernas 177 surge has investors asking what comes next - The Untold Story

It's not every day that a company already worth billions sees its shares nearly triple in a single trading session. Welcome to the world of biotech, because that's exactly what happened to Moderna Inc. (NASDAQ: MRNA) on Wednesday of this week, after the Massachusetts-based company stunned the market with a breakthrough that sent its stock rocketing to a multi-year high.

The catalyst was a set of results from a closely watched trial of an experimental skin cancer vaccine, and the numbers were dramatic enough to reprice the company instantly. Shares closed up a remarkable 177% in a single day, adding to a rally that has seen the stock climb some 465% so far this year.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.